Lung Disease Diagnostic Model Through IgG Sensitization to Microbial Extracellular Vesicles
10.4168/aair.2020.12.4.669
- Author:
Jinho YANG
1
;
Goohyeon HONG
;
Youn-Seup KIM
;
Hochan SEO
;
Sungwon KIM
;
Andrea MCDOWELL
;
Won Hee LEE
;
You-Sun KIM
;
Yeon-Mok OH
;
You-Sook CHO
;
Young Woo CHOI
;
You-Young KIM
;
Young-Koo JEE
;
Yoon-Keun KIM
Author Information
1. Institute of MD Healthcare Inc., Seoul, Korea
- Publication Type:Original Article
- From:Allergy, Asthma & Immunology Research
2020;12(4):669-683
- CountryRepublic of Korea
- Language:English
-
Abstract:
Purpose:Recently, there has been a rise in the interest to understand the composition of indoor dust due to its association with lung diseases such as asthma, chronic obstructive pulmonary disease (COPD) and lung cancer. Furthermore, it has been found that bacterial extracellular vesicles (EVs) within indoor dust particles can induce pulmonary inflammation, suggesting that these might play a role in lung disease.
Methods:We performed microbiome analysis of indoor dust EVs isolated from mattresses in apartments and hospitals. We developed diagnostic models based on the bacterial EVs antibodies detected in serum samples via enzyme-linked immunosorbent assay (ELISA) in this analysis.
Results:Proteobacteria was the most abundant bacterial EV taxa observed at the phylum level while Pseudomonas, Enterobacteriaceae (f) and Acinetobacter were the most prominent organisms at the genus level, followed by Staphylococcus. Based on the microbiome analysis, serum anti-bacterial EV immunoglobulin G (IgG), IgG1 and IgG4 were analyzed using ELISA with EV antibodies that targeted Staphylococcus aureus, Acinetobacter baumannii, Enterobacter cloacae and Pseudomonas aeruginosa. The levels of anti-bacterial EV antibodies were found to be significantly higher in patients with asthma, COPD and lung cancer compared to the healthy control group. We then developed a diagnostic model through logistic regression of antibodies that showed significant differences between groups with smoking history as a covariate. Four different variable selection methods were compared to construct an optimal diagnostic model with area under the curves ranging from 0.72 to 0.81.
Conclusions:The results of this study suggest that ELISA-based analysis of anti-bacterial EV antibodies titers can be used as a diagnostic tool for lung disease. The present findings provide insights into the pathogenesis of lung disease as well as a foundation for developing a novel diagnostic methodology that synergizes microbial EV metagenomics and immune assays.
